Clinical trial
Ziprasidone in the Psychosis Prodrome
NCT00635700
Study timeline
Study start (unknown)2008-03-01Date precision: month
Registry last updated2023-03-27
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Psychosis Prodromeunresolved
Interventions
ziprasidoneDRUG
placeboDRUG
Sponsors & collaborators
Yale Universitylead sponsor
Mapped research locations
BostonMassachusetts, United States1Los AngelesCalifornia, United States1AtlantaGeorgia, United States1San FranciscoCalifornia, United States1DetroitMichigan, United States1New HavenConnecticut, United States1Chapel HillNorth Carolina, United States1La JollaCalifornia, United States1CalgaryAlberta, Canada1WorcesterMassachusetts, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00635700 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.